{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:06Z","timestamp":1740147306284,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gen Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11748-022-01778-7","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:03:44Z","timestamp":1644476624000},"page":"705-713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperlactatemia as a prognostic indicator for contemporary left ventricular assist device implantation"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9963-6970","authenticated-orcid":false,"given":"Yeahwa","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Rinehardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floyd","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"issue":"10","key":"1778_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the american heart association [published correction appears in circulation. 2017 Mar 7;135(10 ):e646] [published correction appears in Circulation. 2017 Sep 5;136(10 ):e196]. Circulation. 2017;135(10):e146\u2013603. https:\/\/doi.org\/10.1161\/CIR.0000000000000485.","journal-title":"Circulation"},{"issue":"20","key":"1778_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","volume":"345","author":"EA Rose","year":"2001","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435\u201343. https:\/\/doi.org\/10.1056\/NEJMoa012175.","journal-title":"N Engl J Med"},{"issue":"4","key":"1778_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000063122","volume":"97","author":"P Razeghi","year":"2002","unstructured":"Razeghi P, Young ME, Ying J, et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology. 2002;97(4):203\u20139. https:\/\/doi.org\/10.1159\/000063122.","journal-title":"Cardiology"},{"issue":"10","key":"1778_CR4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.amjcard.2018.01.041","volume":"121","author":"A Briasoulis","year":"2018","unstructured":"Briasoulis A, Inampudi C, Akintoye E, Adegbala O, Alvarez P, Bhama J. Trends in utilization, mortality, major complications, and cost after left ventricular assist device implantation in the United States (2009 to 2014). Am J Cardiol. 2018;121(10):1214\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2018.01.041.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1778_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.athoracsur.2017.08.057","volume":"105","author":"I Gosev","year":"2018","unstructured":"Gosev I, Kiernan MS, Eckman P, et al. Long-term survival in patients receiving a continuous-flow left ventricular assist device [published correction appears in Ann Thorac Surg. 2018 Apr;105(4):1284]. Ann Thorac Surg. 2018;105(3):696\u2013701. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.08.057.","journal-title":"Ann Thorac Surg."},{"issue":"5","key":"1778_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","volume":"139","author":"RL Kormos","year":"2010","unstructured":"Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):1316\u201324. https:\/\/doi.org\/10.1016\/j.jtcvs.2009.11.020.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1778_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jacc.2012.02.032","volume":"60","author":"JJ Teuteberg","year":"2012","unstructured":"Teuteberg JJ, Ewald GA, Adamson RM, et al. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol. 2012;60(1):44\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.032.","journal-title":"J Am Coll Cardiol"},{"key":"1778_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13019-016-0411-5","volume":"11","author":"NT Mak","year":"2016","unstructured":"Mak NT, Iqbal S, de Varennes B, Khwaja K. Outcomes of post-cardiac surgery patients with persistent hyperlactatemia in the intensive care unit: a matched cohort study. J Cardiothorac Surg. 2016;11:33. https:\/\/doi.org\/10.1186\/s13019-016-0411-5.","journal-title":"J Cardiothorac Surg."},{"issue":"1","key":"1778_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00003246-199201000-00020","volume":"20","author":"BA Mizock","year":"1992","unstructured":"Mizock BA, Falk JL. Lactic acidosis in critical illness. Crit Care Med. 1992;20(1):80\u201393. https:\/\/doi.org\/10.1097\/00003246-199201000-00020.","journal-title":"Crit Care Med"},{"issue":"5","key":"1778_CR10","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1378\/chest.123.5.1361","volume":"123","author":"JM Maillet","year":"2003","unstructured":"Maillet JM, Le Besnerais P, Cantoni M, et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest. 2003;123(5):1361\u20136. https:\/\/doi.org\/10.1378\/chest.123.5.1361.","journal-title":"Chest"},{"issue":"2","key":"1778_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jtcvs.2013.02.003","volume":"146","author":"LA Hajjar","year":"2013","unstructured":"Hajjar LA, Almeida JP, Fukushima JT, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(2):455\u201360. https:\/\/doi.org\/10.1016\/j.jtcvs.2013.02.003.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"1778_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.4103\/0971-9784.191579","volume":"19","author":"R Naik","year":"2016","unstructured":"Naik R, George G, Karuppiah S, Philip MA. Hyperlactatemia in patients undergoing adult cardiac surgery under cardiopulmonary bypass: causative factors and its effect on surgical outcome. Ann Card Anaesth. 2016;19(4):668\u201375. https:\/\/doi.org\/10.4103\/0971-9784.191579.","journal-title":"Ann Card Anaesth"},{"issue":"1","key":"1778_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1051\/ject\/201749007","volume":"49","author":"J Minton","year":"2017","unstructured":"Minton J, Sidebotham DA. Hyperlactatemia and cardiac surgery. J Extra Corpor Technol. 2017;49(1):7\u201315.","journal-title":"J Extra Corpor Technol"},{"issue":"10","key":"1778_CR14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","volume":"36","author":"JK Kirklin","year":"2017","unstructured":"Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB, Naftel DC. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36(10):1080\u20136. https:\/\/doi.org\/10.1016\/j.healun.2017.07.005.","journal-title":"J Heart Lung Transplant"},{"key":"1778_CR15","unstructured":"STS INTERMACS Users\u2019 Guide Version 5.0. Adverse Event Definitions. https:\/\/www.uab.edu\/medicine\/intermacs\/images\/Intermacs-Users-Guide-v5.0-2018-06-28.pdf. Accessed on 5\/21\/2021."},{"issue":"1","key":"1778_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00003246-199701000-00011","volume":"25","author":"RF Raper","year":"1997","unstructured":"Raper RF, Cameron G, Walker D, Bowey CJ. Type B lactic acidosis following cardiopulmonary bypass. Crit Care Med. 1997;25(1):46\u201351. https:\/\/doi.org\/10.1097\/00003246-199701000-00011.","journal-title":"Crit Care Med"},{"issue":"6","key":"1778_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/s0022-5223(02)73291-1","volume":"125","author":"RH Habib","year":"2003","unstructured":"Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg. 2003;125(6):1438\u201350. https:\/\/doi.org\/10.1016\/s0022-5223(02)73291-1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1778_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1536\/ihj.17-146","volume":"59","author":"Y Hoshino","year":"2018","unstructured":"Hoshino Y, Kinoshita O, Ono M. The incidence, risk factors, and outcomes of hyperlactatemia after heart transplantation. Int Heart J. 2018;59(1):81\u20136. https:\/\/doi.org\/10.1536\/ihj.17-146.","journal-title":"Int Heart J"},{"issue":"7","key":"1778_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/CCM.0000000000001059","volume":"43","author":"RS Stephens","year":"2015","unstructured":"Stephens RS, Whitman GJ. Postoperative critical care of the adult cardiac surgical patient. Part I: routine postoperative care. Crit Care Med. 2015;43(7):1477\u201397. https:\/\/doi.org\/10.1097\/CCM.0000000000001059.","journal-title":"Crit Care Med"},{"issue":"3","key":"1778_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jtcvs.2014.10.118","volume":"149","author":"P Jung","year":"2015","unstructured":"Jung P, Pereira MA, Hiebert B, et al. The impact of frailty on postoperative delirium in cardiac surgery patients. J Thorac Cardiovasc Surg. 2015;149(3):869-75.e752. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.10.118.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"1778_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/s0899-9007(01)00627-x","volume":"17","author":"I Mustafa","year":"2001","unstructured":"Mustafa I, Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition. 2001;17(9):756\u201360. https:\/\/doi.org\/10.1016\/s0899-9007(01)00627-x.","journal-title":"Nutrition"},{"issue":"1","key":"1778_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/0884533612457948","volume":"28","author":"A Aggarwal","year":"2013","unstructured":"Aggarwal A, Kumar A, Gregory MP, et al. Nutrition assessment in advanced heart failure patients evaluated for ventricular assist devices or cardiac transplantation. Nutr Clin Pract. 2013;28(1):112\u20139. https:\/\/doi.org\/10.1177\/0884533612457948.","journal-title":"Nutr Clin Pract"},{"issue":"11","key":"1778_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.amjcard.2017.08.004","volume":"120","author":"AC Critsinelis","year":"2017","unstructured":"Critsinelis AC, Kurihara C, Kawabori M, Sugiura T, Civitello AB, Morgan JA. Preoperative prealbumin level as a predictor of outcomes in patients who underwent left ventricular assist device implantation. Am J Cardiol. 2017;120(11):1998\u20132002. https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.004.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1778_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/jocs.14522","volume":"35","author":"Y Hong","year":"2020","unstructured":"Hong Y, Seese L, Hickey G, Mathier M, Thoma F, Kilic A. Preoperative prealbumin does not impact outcomes after left ventricular assist device implantation. J Card Surg. 2020;35(5):1029\u201336. https:\/\/doi.org\/10.1111\/jocs.14522.","journal-title":"J Card Surg"},{"issue":"10","key":"1778_CR25","first-page":"1024","volume":"17","author":"C Schmid","year":"1998","unstructured":"Schmid C, Deng M, Hammel D, Weyand M, Loick HM, Scheld HH. Emergency versus elective\/urgent left ventricular assist device implantation. J Heart Lung Transplant. 1998;17(10):1024\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"1778_CR26","doi-asserted-by":"publisher","first-page":"E64","DOI":"10.1532\/HSF98.2013298","volume":"17","author":"A Tsiouris","year":"2014","unstructured":"Tsiouris A, Morgan JA, Nemeh HW, et al. Does elective or emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices? Heart Surg Forum. 2014;17(2):E64\u201372. https:\/\/doi.org\/10.1532\/HSF98.2013298.","journal-title":"Heart Surg Forum"},{"issue":"4","key":"1778_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S2213-8587(13)70154-2","volume":"2","author":"M Garcia-Alvarez","year":"2014","unstructured":"Garcia-Alvarez M, Marik P, Bellomo R. Stress hyperlactataemia: present understanding and controversy. Lancet Diabetes Endocrinol. 2014;2(4):339\u201347. https:\/\/doi.org\/10.1016\/S2213-8587(13)70154-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1778_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00540-011-1287-0","volume":"26","author":"A Kogan","year":"2012","unstructured":"Kogan A, Preisman S, Bar A, et al. The impact of hyperlactatemia on postoperative outcome after adult cardiac surgery. J Anesth. 2012;26(2):174\u20138. https:\/\/doi.org\/10.1007\/s00540-011-1287-0.","journal-title":"J Anesth"},{"issue":"24","key":"1778_CR29","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMra1309483","volume":"371","author":"JA Kraut","year":"2014","unstructured":"Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371(24):2309\u201319. https:\/\/doi.org\/10.1056\/NEJMra1309483.","journal-title":"N Engl J Med"},{"key":"1778_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43057-020-00029-w","volume":"28","author":"KD Algarni","year":"2020","unstructured":"Algarni KD. The effect of hyperlactatemia timing on the outcomes after cardiac surgery. Cardiothorac Surg. 2020;28:18. https:\/\/doi.org\/10.1186\/s43057-020-00029-w.","journal-title":"Cardiothorac Surg"}],"container-title":["General Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-022-01778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11748-022-01778-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11748-022-01778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:49:47Z","timestamp":1700207387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11748-022-01778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1007\/s11748-022-01778-7","relation":{},"ISSN":["1863-6705","1863-6713"],"issn-type":[{"type":"print","value":"1863-6705"},{"type":"electronic","value":"1863-6713"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kilic is on the medical advisory board for Medtronic, Inc. There are no direct conflicts of interest as it relates to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}